By Wyeth BioPharma Division of Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer | Last revised: 14 September 2011
XYNTHA is an Antihemophilic (Recombinant) Factor indicated for: Control and prevention of bleeding episodes in patients with hemophilia A (1.1) Surgical prophylaxis in patients with hemophilia A (1.2) 1.1 Control and Prevention of Bleeding…
By Antaria Limited | Last revised: 9 September 2011
ZinClear-IM® .50AB UN 3082: Environmentally Hazardous Substance. Liquid, n.o.s (contains zinc oxide). Use: Raw material for sunscreen, skin protection and cosmetic products. Directions: Mix Well Before Use. Made in Australia. Warning: Very toxic…
By Apotheca Company | Last revised: 9 September 2011
To be determined by final processor. Dist. By: Deseret Biologicals. Inc. 469 Parkland Drive Sandy. UT 84070. www.desbio.com CAUTION: For manufacturing, processing or repacking. HELICOBACTER PYLORI SERIES THERAPY 150X. NDC 57520-0826-1. HOMEOPATHIC…
By Grifols Biologicals Inc. | Last revised: 31 August 2011
Factor IX Complex. Profilnine SD is indicated for the prevention and control of bleeding in patients with Factor IX deficiency due to hemophilia B.This product contains non-therapeutic levels of Factor VII, and is not indicated for use in the…